Filters
Supplementation with niacinamide appears protective against some cardiovascular events, such as myocardial infarction and cardiac arrest, suggests a study.
New drug applications approved by US FDA as of 1-15 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Post-bacterial aetiology and the use of systemic corticosteroid appear protective against recurrence or relapse in adult immunoglobulin A vasculitis (IgAV), reveals a study.
A 15-year study recommends taking into consideration the differential risks of hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivations when choosing targeted therapies for the treatment of psoriasis and psoriatic arthritis (PsA), particularly in patients with risk factors for viral reactivation.
Treatment with biologics results in short-term improvements of joint synovitis and enthesitis in patients with subclinical psoriatic arthritis (PsA), specifically for small joint synovitis, a study has shown.
The use of intralesional acyclovir elicits similar efficacy to cryotherapy in the treatment of plantar warts, but the procedure is more painful, according to a study.
The investigational tyrosine kinase 2 (TYK2) inhibitor ICP-332 shows promise in the treatment of atopic dermatitis (AD), with phase II data showing favourable safety profile and efficacy.
Botulinum toxin injections appear to be a safe and efficacious adjunct in the treatment of refractory digital ischaemia in patients with systemic sclerosis, according to a systematic review and individual participant data meta-analysis.
A hand-mounted wearable sensor that delivers closed-loop haptic feedback has the potential helps reduce nocturnal scratching in patients with mild atopic dermatitis (AD), as shown in a small study.
Ultrasound scanning prior to dermal filler treatments results in significant reductions in bruising, which suggests that better vascular visualization can improve procedural outcomes, reports a recent study.
